Search

Author/Creator Kröger, N.

1. Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT. Issue 3 (3rd February 2015)

Authors:
Basak, G. W.; Wiktor‐Jedrzejczak, W.; Labopin, M.; Schoemans, H.; Ljungman, P.; Kobbe, G.; Beguin, Y.; Lang, P.; Koenecke, C.; Sykora, K. W.; te Boome, L.; van Biezen, A.; van der Werf, S.; Mohty, M.; de Witte, T.; Marsh, J.; Dreger, P.; Kröger, N.; Duarte, R.; Ruutu, T.
Journal:
American journal of transplantation
Issue:
Volume 15:Issue 3(2015:Mar.)
Page Start:
705
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P1198: ASSOCIATION OF PRETREATMENT TUMOR CHARACTERISTICS AND CLINICAL OUTCOMES FOLLOWING SECOND-LINE AXICABTAGENE CILOLEUCEL VS STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA. (23rd June 2022)

Authors:
Locke, F. L.; Chou, J.; Vardhanabhuti, S.; Perbost, R.; Dreger, P.; Hill, B. T.; Lee, C.; Zinzani, P. L.; Kröger, N.; López-Guillermo, A.; Greinix, H.; Zhang, W.; Tiwari, G.; To, C.; Cheng, P.; Bot, A.; Shen, R.; Filosto, S.; Galon, J.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1084
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. P1444: IMPACT OF CO-MORBIDITIES ON NON-RELAPSE MORTALITY AND CYTOKINE-RELEASE SYNDROME AFTER CD19 CAR-T CELL THERAPY - A RETROSPECTIVE STUDY FROM THE TCWP OF THE EBMT AND GOCART COALITION. (23rd June 2022)

Authors:
Basak, G.; Peczynski, C.; Koenecke, C.; Terwel, S.; Cabrerizo, Y.; Penack, O.; Moiseev, I.; Schoemans, H.; Fegueux, N.; Potter, V.; Zeerleder, S.; Yakoub-Agha, I.; Collin, M.; Schanz, U.; Dreger, P.; Blaise, D.; Besley, C.; Glass, B.; Mohty, M.; Chabannon, C.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1327
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. P957: CARFILZOMIB, LENALIDOMIDE, DEXAMETHASONE FOLLOWED BY A SECOND AUTO-HCT IS AN EFFECTIVE STRATEGY IN FIRST RELAPSE MULTIPLE MYELOMA: A STUDY OF THE CHRONIC MALIGNANCIES WORKING PARTY OF EBMT. (23rd June 2022)

Authors:
Tilmont, R.; Yakoub-Agha, I.; Eikema, D.-J.; Zinger, N.; Haenel, M.; Schaap, N.; Herrera Arroyo, C.; Schuermans, C.; Bethge, W.; Engelhardt, M.; Kuball, J.; Michieli, M.; Schub, N.; Wilson, K. M. O.; Bourhis, J. H.; Mateos, M. V.; Robin, N.; Jost, E.; Kröger, N.; Moraleda, J. M.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
847
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. What is the outcome in patients with acute leukaemia who survive severe acute graft‐versus‐host disease?. (3rd November 2017)

Authors:
Ringdén, O.; Labopin, M.; Sadeghi, B.; Mailhol, A.; Beelen, D.; Fløisand, Y.; Ghavamzadeh, A.; Finke, J.; Ehninger, G.; Volin, L.; Socié, G.; Kröger, N.; Stuhler, G.; Ganser, A.; Schmid, C.; Giebel, S.; Mohty, M.; Nagler, A.
Journal:
Journal of internal medicine
Issue:
Volume 283:Number 2(2018)
Page Start:
166
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗